These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
387 related items for PubMed ID: 6410549
1. Hemotherapy in patients undergoing blood group incompatible bone marrow transplantation. Lasky LC, Warkentin PI, Kersey JH, Ramsay NK, McGlave PB, McCullough J. Transfusion; 1983; 23(4):277-85. PubMed ID: 6410549 [Abstract] [Full Text] [Related]
2. Transplantation of ABO-incompatible bone marrow and peripheral blood stem cell components. Rowley SD, Liang PS, Ulz L. Bone Marrow Transplant; 2000 Oct; 26(7):749-57. PubMed ID: 11042656 [Abstract] [Full Text] [Related]
3. Hemolysis of transfused group O red blood cells in minor ABO-incompatible unrelated-donor bone marrow transplants in patients receiving cyclosporine without posttransplant methotrexate. Gajewski JL, Petz LD, Calhoun L, O'Rourke S, Landaw EM, Lyddane NR, Hunt LA, Schiller GJ, Ho WG, Champlin RE. Blood; 1992 Jun 01; 79(11):3076-85. PubMed ID: 1586749 [Abstract] [Full Text] [Related]
4. Transplantation of major ABO-incompatible bone marrow depleted of red cells by hydroxyethyl starch. Warkentin PI, Hilden JM, Kersey JH, Ramsay NK, McCullough J. Vox Sang; 1985 Jun 01; 48(2):89-104. PubMed ID: 2416122 [Abstract] [Full Text] [Related]
6. Transfusion of RhD-incompatible blood components in RhD-negative blood marrow transplant recipients. Asfour M, Narvios A, Lichtiger B. MedGenMed; 2004 Jul 13; 6(3):22. PubMed ID: 15520646 [Abstract] [Full Text] [Related]
7. In vivo adsorption of isohemagglutinins with fresh frozen plasma in major ABO-incompatible bone marrow transplantation. Webb IJ, Soiffer RJ, Andersen JW, Cohen CA, Freeman A, Sugrue M, Ritz J, Anderson KC. Biol Blood Marrow Transplant; 1997 Nov 13; 3(5):267-72. PubMed ID: 9450922 [Abstract] [Full Text] [Related]
8. Transfusion of donor-type red cells as a single preparative treatment for bone marrow transplants with major ABO incompatibility. Nussbaumer W, Schwaighofer H, Gratwohl A, Kilga S, Schönitzer D, Nachbaur D, Niederwieser D. Transfusion; 1995 Jul 13; 35(7):592-5. PubMed ID: 7631393 [Abstract] [Full Text] [Related]
9. Engraftment of early erythroid progenitors is not delayed after non-myeloablative major ABO-incompatible haematopoietic stem cell transplantation. Maciej Zaucha J, Mielcarek M, Takatu A, Little MT, Gooley T, Baker J, Maloney DG, Sandmaier BM, Maris M, Chauncey T, Storb R, Torok-Storb B. Br J Haematol; 2002 Dec 13; 119(3):740-50. PubMed ID: 12437653 [Abstract] [Full Text] [Related]
10. ABO-incompatible bone-marrow transplantation: removal of red blood cells from donor marrow avoiding recipient antibody depletion. Blacklock HA, Gilmore MJ, Prentice HG, Hazlehurst GR, Evans JP, Ma DD, Knight CB, Hoffbrand AV. Lancet; 1982 Nov 13; 2(8307):1061-4. PubMed ID: 6127543 [Abstract] [Full Text] [Related]
11. [Immunohematologic surveillance of patients treated with ABO incompatible bone marrow allografts]. Mizon P, Jouet JP, Vanhaesbroucke C, Villard F, Wibaut B, Goudemand J. Transfus Clin Biol; 1994 Nov 13; 1(4):271-7. PubMed ID: 7921283 [Abstract] [Full Text] [Related]
12. Rh antibodies against the pretransplant red cells following Rh-incompatible bone marrow transplantation. Heim MU, Schleuning M, Eckstein R, Huhn D, Siegert W, Clemm C, Ledderose G, Kolb HJ, Wilmanns W, Mempel W. Transfusion; 1988 Nov 13; 28(3):272-5. PubMed ID: 3130695 [Abstract] [Full Text] [Related]
13. The devil is in the details: retention of recipient group A type 5 years after a successful allogeneic bone marrow transplant from a group O donor. Cooling LLW, Herrst M, Hugan SL. Immunohematology; 2018 Jan 13; 33(1):19-22. PubMed ID: 29608324 [Abstract] [Full Text] [Related]
14. Consequences of ABO incompatibility in multiple myeloma patients undergoing peripheral blood stem cell transplantation after reduced intensity conditioning. Marenchino D, Maddalena L, Balbo R, Avonto I, Menardi G, Prucca M, Perotti L, Mordini N, Peano G. Blood Transfus; 2011 Jan 13; 9(1):79-85. PubMed ID: 21084015 [Abstract] [Full Text] [Related]
15. A study of the effect of ABO incompatible plasma in platelet concentrates transfused to bone marrow transplant recipients. Shanwell A, Ringdén O, Wiechel B, Rumin S, Akerblom O. Vox Sang; 1991 Jan 13; 60(1):23-7. PubMed ID: 2053326 [Abstract] [Full Text] [Related]
16. Plasma exchange and immunoadsorption for removal of antibodies prior to ABO incompatible bone marrow transplant. Bensinger WI. Artif Organs; 1981 Aug 13; 5(3):254-8. PubMed ID: 7030280 [Abstract] [Full Text] [Related]
17. [ABO-incompatible allogeneic bone marrow transplantation]. Xu L, Guo N, Wang S. Zhonghua Xue Ye Xue Za Zhi; 1999 Aug 13; 20(8):413-5. PubMed ID: 11721421 [Abstract] [Full Text] [Related]
18. ABO-incompatible bone marrow transplantation: preparation by plasma exchange and in vivo antibody absorption. Berkman EM, Caplan S, Kim CS. Transfusion; 1978 Aug 13; 18(4):504-8. PubMed ID: 356351 [Abstract] [Full Text] [Related]
19. Severe hemolytic anemia due to multiple red cell alloantibodies after an ABO-incompatible allogeneic bone marrow transplant. López A, de la Rubia J, Arriaga F, Jiménez C, Sanz GF, Carpio N, Marty ML. Transfusion; 1998 Mar 13; 38(3):247-51. PubMed ID: 9563404 [Abstract] [Full Text] [Related]
20. Severe delayed hemolytic transfusion reaction complicating an ABO-incompatible bone marrow transplantation. Warkentin PI, Yomtovian R, Hurd D, Brunning R, Swanson J, Kersey JH, McCullough J. Vox Sang; 1983 Mar 13; 45(1):40-7. PubMed ID: 6349125 [Abstract] [Full Text] [Related] Page: [Next] [New Search]